Ryman Healthcare, a leading name in the aged care sector, is headquartered in New Zealand and operates extensively across the country and in Australia. Founded in 1984, the company has established itself as a pioneer in retirement living and aged care, with a commitment to providing high-quality services tailored to the needs of older adults. Ryman Healthcare offers a unique blend of independent living, assisted living, and rest home care, all designed to foster a sense of community and well-being among residents. The company is renowned for its innovative approach, including the development of purpose-built facilities that prioritise comfort and safety. With a strong market position, Ryman Healthcare has received numerous accolades for its services and facilities, reflecting its dedication to excellence in the industry. As it continues to expand, Ryman remains focused on enhancing the lives of its residents through compassionate care and vibrant living environments.
How does Ryman Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ryman Healthcare's score of 31 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Ryman Healthcare, headquartered in New Zealand, reported total carbon emissions of approximately 14,000,000 kg CO2e. This figure includes 4,318,000 kg CO2e from Scope 1 emissions, 8,234,000 kg CO2e from Scope 2 emissions, and 4,188,000 kg CO2e from Scope 3 emissions, which encompasses business travel and waste generated in operations. Ryman Healthcare has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030, using FY2021 as the baseline year. Additionally, the company plans for 75.5% of its suppliers, based on spend, to have science-based targets by FY2028. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to limiting global warming to 1.5°C. In 2021, Ryman's emissions were slightly lower, with Scope 1 emissions at 4,317,000 kg CO2e and Scope 2 emissions at 8,333,000 kg CO2e, indicating a stable emission profile over the years. The company is committed to enhancing its sustainability practices and reducing its carbon footprint in the healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2024 | |
|---|---|---|
| Scope 1 | 4,317,000 | 0,000,000 |
| Scope 2 | 8,333,000 | 0,000,000 |
| Scope 3 | 3,600,000 | 0,000,000 |
Ryman Healthcare's Scope 3 emissions, which increased by 15% last year and increased by approximately 15% since 2021, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 25% of total emissions under the GHG Protocol, with "Waste Generated in Operations" being the largest emissions source at 66% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ryman Healthcare has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Ryman Healthcare's sustainability data and climate commitments